197 related articles for article (PubMed ID: 1707469)
21. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
23. Expression and regulation of interleukin-1 mRNA and interleukin-1 receptors in human B-cell lines.
Bertoglio J; Dosda J; Stancou R; Wollman E; Fradelizi D
J Mol Cell Immunol; 1989; 4(3):139-47; discussion 148. PubMed ID: 2527510
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting the in vitro evolution of a myeloma cell line.
Scibienski RJ; Paglieroni T; Caggiano V; Lemongello D; Gumerlock PH; Mackenzie MR
Leukemia; 1992 Sep; 6(9):940-7. PubMed ID: 1518305
[TBL] [Abstract][Full Text] [Related]
25. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
Cheung WC; Van Ness B
Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?
Kovacs E
Leuk Res; 2010 Jul; 34(7):912-6. PubMed ID: 19762082
[TBL] [Abstract][Full Text] [Related]
27. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
28. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
29. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
30. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism.
Takizawa H; Ohtoshi T; Ohta K; Yamashita N; Hirohata S; Hirai K; Hiramatsu K; Ito K
Cancer Res; 1993 Sep; 53(18):4175-81. PubMed ID: 8364912
[TBL] [Abstract][Full Text] [Related]
32. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
Takahashi T; Okuno Y; Ohsugi Y
Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
[TBL] [Abstract][Full Text] [Related]
33. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
Bataille R; Klein B
Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
[TBL] [Abstract][Full Text] [Related]
34. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
[TBL] [Abstract][Full Text] [Related]
35. TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812.
Nilsson G; Carlsson M; Jones I; Ahlstedt S; Matsson P; Nilsson K
Immunology; 1994 Jan; 81(1):73-8. PubMed ID: 8132223
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 production by human melanoma cell lines.
Lee JD; Sievers TM; Skotzko M; Chandler CF; Morton DL; McBride WH; Economou JS
Lymphokine Cytokine Res; 1992 Jun; 11(3):161-6. PubMed ID: 1391235
[TBL] [Abstract][Full Text] [Related]
37. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Hitzler JK; Martinez-Valdez H; Bergsagel DB; Minden MD; Messner HA
Blood; 1991 Oct; 78(8):1996-2004. PubMed ID: 1912582
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells.
Colotta F; Bussolino F; Polentarutti N; Guglielmetti A; Sironi M; Bocchietto E; De Rossi M; Mantovani A
Exp Cell Res; 1993 Jun; 206(2):311-7. PubMed ID: 7684696
[TBL] [Abstract][Full Text] [Related]
39. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth.
Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Fukumoto M; Okada T; Okada H; Imura H
Leukemia; 1991 Jul; 5(7):585-91. PubMed ID: 2072743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]